These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32032639)

  • 21. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
    Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L
    Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical management of unwanted pregnancy in France: modalities and outcomes. The aMaYa study.
    Nisand I; Bettahar K;
    Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():13-8. PubMed ID: 25462213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early medical abortion with self-administered low-dose mifepristone in combination with misoprostol.
    Song LP; Tang SY; Li CL; Zhou LJ; Mo XT
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1705-1711. PubMed ID: 29974571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.
    Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM
    Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety, Efficacy and Acceptability of Early First Trimester Abortion using Oral Mifepristone and Sublingual Misoprostol.
    Shrestha D; Aryal S; Sharma B
    J Nepal Health Res Counc; 2018 Oct; 16(3):269-273. PubMed ID: 30455484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial.
    Schreiber CA; Creinin MD; Reeves MF; Harwood BJ
    Contraception; 2006 Dec; 74(6):458-62. PubMed ID: 17157102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical preparation for first trimester surgical abortion.
    Kapp N; Lohr PA; Ngo TD; Hayes JL
    Cochrane Database Syst Rev; 2010 Feb; (2):CD007207. PubMed ID: 20166091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globally.
    Durocher J; Kilfedder C; Frye LJ; Winikoff B; Srinivasan K
    Sex Reprod Health Matters; 2021 Dec; 29(1):1982460. PubMed ID: 34719353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
    Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L
    JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First trimester abortion with mifepristone and vaginal misoprostol.
    Knudsen UB
    Contraception; 2001 May; 63(5):247-50. PubMed ID: 11448463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol.
    Li L; Zhou Z; Huang L
    Acta Obstet Gynecol Scand; 2009; 88(6):673-9. PubMed ID: 19353331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
    Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
    Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and Safety of Lower Doses of Mifepristone Combined With Misoprostol for the Termination of Ultra-Early Pregnancy: A Dose-Ranging Randomized Controlled Trial.
    Li CL; Chen DJ; Song LP; Wang Y; Zhang ZF; Liu MX; Chen WL
    Reprod Sci; 2015 Jun; 22(6):706-11. PubMed ID: 25394644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration.
    Davis A; Westhoff C; De Nonno L
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):141-4. PubMed ID: 10846324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of medical abortion prior to 6 gestational weeks: a systematic review.
    Kapp N; Baldwin MK; Rodriguez MI
    Contraception; 2018 Feb; 97(2):90-99. PubMed ID: 28935220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical abortion in the second trimester.
    Tang OS; Ho PC
    Best Pract Res Clin Obstet Gynaecol; 2002 Apr; 16(2):237-46. PubMed ID: 12041965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous Compared With Interval Medical Abortion Regimens Where Home Use Is Restricted.
    Lohr PA; Starling JE; Scott JG; Aiken ARA
    Obstet Gynecol; 2018 Apr; 131(4):635-641. PubMed ID: 29528933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for unsuccessful medical abortion with mifepristone and misoprostol.
    Haimov-Kochman R; Arbel R; Sciaky-Tamir Y; Brzezinski A; Laufer N; Yagel S
    Acta Obstet Gynecol Scand; 2007; 86(4):462-6. PubMed ID: 17486469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.